/Companies

Maxwell Biomedical

2 known investors

Find your way into Maxwell Biomedical

Sign up to see every warm intro you have to Maxwell Biomedical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Maxwell Biomedical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.

Founders & leadership

RWRandy Werneth
Randy WernethCEO, President
TCTimothy Corvi
Timothy CorviSr. VP, R&D
DC
Derrick ChouVP, Science & Technology
BC
Ben CoppolaDirector of SRT
WB
Walter BomelaDynamical Systems Scientist
JC
J. Chris FlahertyIP Strategist
RÓ
Ragnar ÓlafssonSr. Pr. Systems Engineer

Investors · 2

Related companies · 4

Companies working in the same space as Maxwell Biomedical.

Frequently asked questions

What does Maxwell Biomedical do?
Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.
Who are Maxwell Biomedical's investors?
Maxwell Biomedical's investors include Broadview Ventures, RiverVest Venture Partners.